| Literature DB >> 25609475 |
Patricia Svolos, Evanthia Kousi, Eftychia Kapsalaki, Kyriaki Theodorou, Ioannis Fezoulidis, Constantin Kappas, Ioannis Tsougos.
Abstract
The role of conventional Magnetic Resonance Imaging (MRI) in the detection of cerebral tumors has been well established. However its excellent soft tissue visualization and variety of imaging sequences are in many cases non-specific for the assessment of brain tumor grading. Hence, advanced MRI techniques, like Diffusion-Weighted Imaging (DWI), Diffusion Tensor Imaging (DTI) and Dynamic-Susceptibility Contrast Imaging (DSCI), which are based on different contrast principles, have been used in the clinical routine to improve diagnostic accuracy. The variety of quantitative information derived from these techniques provides significant structural and functional information in a cellular level, highlighting aspects of the underlying brain pathophysiology. The present work, reviews physical principles and recent results obtained using DWI/DTI and DSCI, in tumor characterization and grading of the most common cerebral neoplasms, and discusses how the available MR quantitative data can be utilized through advanced methods of analysis, in order to optimize clinical decision making.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25609475 PMCID: PMC4331825 DOI: 10.1186/1470-7330-14-20
Source DB: PubMed Journal: Cancer Imaging ISSN: 1470-7330 Impact factor: 3.909
Figure 1Low-grade glioma in a 55-year-old woman. a) High signal intensity on a T2-weighted image, b) no contrast enhancement on a 3D-SPGR image and c) an isointense signal on a diffusion-weighted image. The lesion shows increased ADC (d), lower FA (e) and no significant perfusion (f) on the corresponding parametric maps.
Figure 2Anaplastic Astrocytoma in a 71-year-old man. a) T2-weighted image shows increased signal intensity with peritumoral edema, b) heterogeneous contrast enhancement on a post-contrast 3D-SPGR image and c) restricted diffusion in the solid portion of the tumor. The lesion is hypointense on the ADC map (d), presents low FA (e) and increased perfusion on the rCBV map (f).
Figure 3Glioblastoma multiforme in a 65-year-old woman. Axial T2-weighted (a) and T1-weighted post contrast (b) images demonstrate a right temporal lesion with surrounding edema and ring-shaped enhancement. On the DW-image the lesion presents low signal intensity (c) resulting in higher intratumoral ADC (d), lower intratumoral FA (e), and high peritumoral rCBV (f), reflecting tumor infiltration in the surrounding parenchyma.
Published studies regarding glioma grading and the differentiation of metastatic tumors (MT) from high-grade gliomas (HGG)
| Kono et al. [ | 17 | Intra/Peritumoral | DWI | Intratumoral ADC higher in LGG than GBM | |
| | Kremer et al. [ | 36 | Intratumoral | DSCI | rCBV lower in LGG than HGG |
| | Beppu et al. [ | 31 | Intratumoral | DTI | FA lower in LGG than HGG |
| | Preul et al. [ | 33 | Intratumoral | DSCI | rCBV lower in LGG than HGG |
| | Law et al. [ | 63 | Intratumoral | DSCI | rCBV lower in LGG than GBM |
| | Inoue et al. [ | 41 | Intratumoral | DTI | MD higher in LGG than HGG |
| FA lower in LGG than HGG | |||||
| | Fan et al. [ | 22 | Intra/Peritumoral | DWI | Intratumoral ADC higher in LGG than AA |
| | Hakyemez et al. [ | 33 | Intratumoral | DSCI | rCBV lower in LGG than GBM |
| | Stadlbauer et al. [ | 20 | Intratumoral | DTI | FA higher in LGG than HGG |
| | Zonari et al. [ | 105 | Intratumoral | DSCI | rCBV lower in LGG than GBM |
| | Lee et al. [ | 27 | Intratumoral | DTI | MD higher in LGG than HGG |
| | Di Costanzo et al. [ | 36 | Intra/Peritumoral | DSCI | Intra/Peritumoral rCBV lower in LGG than HGG |
| | Rizzo et al. [ | 35 | Intratumoral | DSCI | rCBV lower in LGG than HGG |
| | Senturk et al. [ | 26 | Intratumoral | DSCI | rCBV lower in LGG than HGG |
| | Chen et al. [ | 31 | Intra/Peritumoral | DTI | Peritumoral FA higher in LGG than HGG |
| | Liu et al. [ | 52 | Intratumoral | DTI | FA lower in LGG than HGG |
| | Svolos et al. [ | 73 | Intra/Peritumoral | DWI | Intratumoral ADC higher in LGG than HGG |
| | Peritumoral ADC lower in LGG than HGG | ||||
| DSCI | Intra/Peritumoral rCBV lower in LGG than HGG | ||||
| Chiang et al. [ | 12 | Intra/Peritumoral | DSCI | Peritumoral rCBV lower in MT than HGG | |
| | Lu et al. [ | 20 | Intra/Peritumoral | DTI | Peritumoral MD higher in MT than GBM |
| | Server et al. [ | 82 | Intra/Peritumoral | DWI | Intratumoral ADC lower in MT than GBM |
| | Pavlisa et al. [ | 40 | Intra/Peritumoral | DWI | Peritumoral ADC higher in MT than GBM |
| | Wang et al. [ | 63 | Intra/Peritumoral | DTI | Intra/Peritumoral FA lower in MT than GBM |
| | Senturk et al. [ | 18 | Intra/Peritumoral | DSCI | Peritumoral rCBV lower in MT than GBM |
| | Hakyemez et al. [ | 48 | Intra/Peritumoral | DSCI | Peritumoral rCBV lower in MT than GBM |
| | Lee et al. [ | 73 | Intra/Peritumoral | DWI | Peritumoral ADC higher in MT than GBM |
| | Wang et al. [ | 51 | Intra/Peritumoral | DTI | Intra/Peritumoral FA lower in MT than GBM |
| DSCI | Peritumoral rCBV lower in MT than GBM | ||||
| | Server et al. [ | 61 | Intra/Peritumoral | DSCI | Peritumoral rCBV lower in MT than GBM |
| | Tsougos et al. [ | 49 | Intra/Peritumoral | DSCI | Peritumoral rCBV lower in MT than GBM |
| | Lehmann et al. [ | 24 | Peritumoral | DSCI | rCBV lower in MT than GBM. |
| Svolos et al. [ | 71 | Intra/Peritumoral | DTI | Peritumoral FA lower in MT than HGG | |
| DSCI | Peritumoral rCBV lower in MT than HGG |
The number of patients, the investigated tumor areas, the most useful imaging techniques and the diagnostic outcome for each case are summarized in the Table.
Figure 4A typical Meningioma in a 60-year-old man. Axial T2-weighted (a) and postcontrast T1-weighted (b) images demonstrate a large heterogeneous enhanced left frontal mass with an intense mass effect. The lesion presents areas of restricted diffusion (c), isointensity on the ADC map (d), hypointensity on the FA map (e) and elevated blood volume (f).
Published studies regarding different tumor comparisons
| | Kremer et al. [ | 37 | Intratumoral | DSCI | rCBV higher in MNG than HGG |
| | Tropine et al. [ | 22 | Intra/Peritumoral | DTI | Intratumoral MD lower in MNG than HGG |
| Intratumoral FA higher in MNG than HGG | |||||
| | Hakyemez et al. [ | 49 | Intratumoral | DSCI | rCBV higher in MNG than HGG |
| | De Belder et al. [ | 35 | Intra/Peritumoral | DTI | Intratumoral ADC lower in MNG than HGG |
| Intratumoral FA higher in MNG than HGG | |||||
| Peritumoral FA higher in MNG than HGG | |||||
| | Svolos et al. [ | 77 | Intra/Peritumoral | DWI | Intra/Peritumoral ADC lower in MNG than HGG |
| DTI | Intra/Peritumoral FA higher in MNG than HGG | ||||
| DSCI | Peritumoral rCBV lower in MNG than HGG | ||||
| Kremer et al. [ | 21 | Intratumoral | DSCI | rCBV higher in MNG than MT | |
| | Hakyemez et al. [ | 48 | Intratumoral | DSCI | rCBV higher in MNG than MT |
| | Toh et al. [ | 26 | Peritumoral | DTI | MD lower in MNG than MT |
| FA higher in MNG than MT | |||||
| | Svolos et al. [ | 42 | Intra/Peritumoral | DWI | Intra/Peritumoral ADC lower in MNG than MT |
| DTI | Intra/Peritumoral FA higher in MNG than MT | ||||
| Guo et al. [ | 28 | Intratumoral | DWI | ADC lower in PCL than HGG | |
| | Cho et al.[ | 29 | Intratumoral | DSCI | rCBV lower in PCL than HGG |
| | Kremer et al. [ | 32 | Intratumoral | DSCI | rCBV lower in PCL than GBM |
| | Hartmann et al. [ | 24 | Intratumoral | DSCI | rCBV lower in PCL than GBM |
| | Yamasaki et al. [ | 44 | Intratumoral | DWI | ADC lower in PCL than GBM |
| | Calli et al. [ | 25 | Intratumoral | DWI | ADC lower in PCL than GBM |
| DSCI | rCBV lower in PCL than GBM | ||||
| | Hakyemez et al. [ | 31 | Intratumoral | DSCI | rCBV lower in PCL than HGG |
| | Rollin et al. [ | 10 | Intra/Peritumoral | DSCI | Intra/Peritumoral rCBV lower in PCL than HGG |
| | Toh et al. [ | 20 | Intratumoral | DTI | MD and FA lower in PCL than GBM |
| | Kinoshita et al. [ | 14 | Intratumoral | DTI | MD lower in PCL than HGG |
| | Server et al. [ | 64 | Intra/Peritumoral | DWI | Intratumoral ADC lower in PCL than HGG |
| | Liao et al. [ | 28 | Intratumoral | DSCI | rCBV lower in PCL than HGG |
| | Bendini et al. [ | 23 | Intratumoral | DSCI | rCBV lower in PCL than HGG |
| | Wang et al. [ | 42 | Intra/Peritumoral | DTI | Intratumoral MD and FA lower in PCL than GBM |
| | Peritumoral FA lower in PCL than GBM | ||||
| DSCI | Intra/Peritumoral rCBV lower in PCL than GBM | ||||
| Kremer et al. [ | 16 | Intratumoral | DSCI | rCBV lower in PCL than MT. | |
| | Cho et al. [ | 15 | Intratumoral | DSCI | rCBV lower in PCL than MT. |
| | Yamasaki et al. [ | 37 | Intratumoral | DWI | ADC lower in PCL than MT |
| | Hakyemez et al. [ | 30 | Intratumoral | DSCI | rCBV lower in PCL than MT |
| | Server et al. [ | 28 | Intra/Peritumoral | DWI | Intratumoral ADC lower in PCL than MT |
| | Wang et al. [ | 41 | Intra/Peritumoral | DTI | Intratumoral MD lower in PCL than MT |
| Hartmann et al. [ | 17 | Intratumoral | DWI | ADC lower in abscess than other tymors. | |
| | Chan et al. [ | 12 | Intra/Peritumoral | DWI | Intratumoral ADC lower in abscess than other tumors |
| | Peritumoral ADC higher in abscess than other tumors | ||||
| DSCI | Intra/Peritumoral rCBV lower in abscess than other tumors | ||||
| | Chang et al. [ | 26 | Intratumoral | DWI | ADC lower in abscess than other tumors |
| | Lai et al. [ | 14 | Intratumoral | DWI | ADC lower in abscess than other tumors |
| | Nadal-Desbarats et al. [ | 26 | Intratumoral | DWI | ADC lower in abscess than other tumors |
| | Holmes et al. [ | 8 | Intratumoral | DSCI | rCBV lower in abscess than other tumors |
| | Hakyemez et al. [ | 55 | Intratumoral | DSCI | rCBV lower in abscess than other tumors |
| | Nath et al. [ | 53 | Intratumoral | DTI | MD lower and FA higher in abscess than other tumors |
| Reiche et al. [ | 17 | Intratumoral | DWI | ADC lower in abscess than other tumors | |
| DTI | MD lower and FA higher in abscess than other tumors |
The number of patients, investigated tumor areas, most useful imaging techniques and the diagnostic outcome for each case are summarized in the Table.
Note- MNG = Meningioma, HGG = High-grade glioma, MT = Metastatic Tumor, PCL = Primary Cerebral Lymphoma.
Figure 5Intracranial lung metastasis in a 68 year-old-man. a) T2-weighted image, b) ring-shaped enhancement on a T1-weighted post contrast edema, c) restricted diffusion in the periphery of the tumor. Increased intratumoral ADC (d), decreased FA (e) and elevated perfusion in the peripheral solid part of the lesion (f).
Figure 6Primary Cerebral Lymphoma in a 59-year-old-woman. a) High signal intensity with peritumoral edema on a T2-weighted image, b) intense contrast-enhancement on a T1-weighted post contrast image and c) hyperintensity on a DW image. Decreased intratumoral ADC (d) and FA (e). The rCBV map shows moderate perfusion within the lesion (f).